+3 8(066) 185-39-18
fПредмет:
Тип роботи:
Стаття
К-сть сторінок:
20
Мова:
Українська
definition. Ann Intern Med 1988; 108: 387-389.
Fukuda K, Straus S, Hickie I, et al. The Chronic Fatigue Syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 953-959.
De Meirleir K, Bisbal C, Campine I, et al. A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome. Am J Med 2000; 108: 99-105.
Englebienne P, Herst CV, De Smet K, et al. Interactions between RNase L ankyrin-like domain and ABC transportes as a possible origin for pain, ion transport, CNS and immune disorders of Chronic Fatigue Immune Dysfunction Syndrome. J Chronic Fatigue Syndr 2001; 8 (3/4) : 83-102.
Chaudhuri A, Behan PO. Neurological dyfunction in chronic fatigue syndrome. J Chronic Fatigue Syndr 2000; 6 (3/4) : 51-68.
Watson WS, McMillan DC, Chaudhuri A, et al. Increased resting energy expenditure in the chronic fatigue syndrome. J Chronic Fatigue Syndr 1998; 4: 3-14.
Burnet RB, Yeap BB, Chatterton BE, et al. Chronic fatigue syndrome: is total body potassium important? Med J Aust 1996; 164: 384.
Flynn MA, Nolph GB, Krause G. Comparison of body composition measured by total body potassium and infrared interactance. J Am Coll Nutr 1995; 14: 652-5.
Schaefer F, Georgi M, Zieger A, et al. Usefulness of bioelectric impedance and skinfold measurements in predicting fat-free mass derived from total body potassium in children. Pediatr Res 1994; 35: 617-624.
Cohn SH, Dombrowski CS. Absolute measurement of whole-body potassium by gamma-ray spectrometry. J Nucl Med 1970; 11: 239-46.
Suhadolnik RJ, Peterson DL, O'Brien K, et al. Biochemical evidence for a novel molecular weight 2-5A-dependent RNase L in Chronic Fatigue Syndrome. J Interferon Cytokine Res 1997; 17: 377-385.
Dewaide PA, Lefebure P, Van Cauwenberge H, et al. Détermination du potassium total par anthropogammamétrie. Quelques applications en pathologie interne. Acta Clin Belgl970; 25: 193-214.
Bennett V, Otto E, Kunimoto M, et al. Diversity of ankyrins in the brain. Biochem Soc Trans 1991; 19: 1034-1039.
Bisbal C, Martinand C, Silhol M, et al. Cloning and characterization of a RNase L inhibitor. J Biol Chem 1995; 270: 13308-13317.
Sherwood L. Human physiology: from cells to systems. Belmont: Wadsworth Publishing Company. 1997. p. 491.
Sanz JM, Di Vergilio F. Kinetics and mechanism of ATP-dependent IL-lp release from microglial cells. J Immunol 2000; 164: 4893-4898.
Lévite M, Cahalon L, Peretz A, et al. Extracellular K+ and opening of voltage-gated potassium channels activate T cell integrin function: physical and functional association between Kvl. 3 channels and pi integrins. J Exp Med 2000; 191: 1167-1176.
Lai Z-F, Chen Y-Z, Nishimura Y, et al. An amiloride-sensitive and voltage-dependent Na+ channel in an HLA-DR-restricted human T-cell clone. J Immunol 2000; 165: 83-90.
Linde A, Andersson B, Svensson SB, et al. Serum levels of lymphokines and soluble cellular receptors in primary EBV infection and inpatients with chronic fatigue syndrome. J Infect Dis 1992; 165: 994-1000.
Patarca R, Klimas NG, Lutgendorf S, et al. Dysregulated expression of tumor necrosis factor in Chronic Fatigue Syndrome, interrelations with cellular sources and patterns of soluble immune mediator expression. Clin Infect Dis 1994; 18: S147-153.
Lloyd A, Gandevia S, Brockman A, et al. Cytokine production and fatigue in patients with chronic fatigue syndrome and healthy control subjects in response to exercise. Clin Infect Dis 1994; 18: SI S142-6.
Peakman M, Deale A, Field R, et al. Clinical improvement in Chronic Fatigue Syndrome is not associated with lymphocyte subsets of function or activation. Clin Immunol Immunopathol 1997; 82: 83-91.
Fanger CM, Rauer H, Neben AL, et al. Calcium-activated potassium channels sustain calcium signalling in T lymphocytes. J Biol Chem 2001; 276: 12249-12256.
Haverstick DM, Dicus M, Resnick MS, et al. A role for protein kinase Cpi in the regulation of Ca2+ entry in Jurkat T cells. J Biol Chem 1997; 272: 15426-15433.
Gardner P. Calcium and T lymphocyte activation. Cell 1989; 59: 15-20.
Hosfield CM, Elce JS, Davies PL, et al. Crystal structure of calpain reveals the structural basis for Ca2+-dependent protease activity and a novel mode of enzyme activation. EMBO J 1999; 18: 6880-6889.
Mehmet H. Caspases find a new place to hide. Nature 2000; 403: 29-30.
Zhang Q, Zhou X-D, Denny T, et al. Changes in immune parameters seen in gulf war veterans but not in civilians with Chronic Fatigue Syndrome. Clin Diagn Lab Immunol 1999; 6: 6-13.
Levine PH, Whiteside TL, Friberg D, et al. Dysfunction of natural killer cell activity in a family with chronic fatigue syndrome. Clin Immunol Immunopathol 1998; 88: 99-104.
Whiteside TL, Friberg D. Natural killer cells and natural killer cell activity in chronic fatigue syndrome. Am J Med 1998; 105: 27S-34S.
Mawle AC, Nisenbaum R, Dobbins JG, et al. Immune responses associated with chronic fatigue syndrome: a case-control study. J Infect Dis 1997; 175: 136-41.
Tirelli U, Marotta G, Improta S, et al. Immunological abnormalities in patients with chronic fatigue syndrome. Scand J Immunol 1994; 40: 601-8.
Morrison LJ, Behan WH, Behan PO. Changes in natural killer cell phenotype in patients with post-viral fatigue syndrome. Clin Exp Immunol 1991; 83: 441-6.
Klimas NG, Salvato FR, Morgan R, et al. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 1990; 28: 1403-10.
Preedy VR, Smith DG, Salisbury JR, et al. Biochemical and muscle studies in patients with acute onset post-viral fatigue syndrome. J Clin Pathol 1993; 46: 722-6.
Herst CV, De Smet K, D'Haene A, et al. The interaction of RNase L ankyrin domain with ABC transporters might explain pain and many of the physiological disorders of CFS. Abstract presented at the AACFS fifth international research, clinical and patient conference. Abstract book page 71.